TechConnect Innovation Program

TiO2 nanowired Cerebrolysin for neuroprotection in concussive head injury

Uppsala University, Uppland, Sweden

TECHNOLOGY SUMMARY

Our innovation shows that intravenous administration of TiO2 nanowired-tagged Cerebrolysin (Ever NeuroPharma, Austria) that is a balanced composition of several neurotrophic factors and active peptide fragments enhanced neuroprotection after concussive head injury (CHI) in rat model (5 ml/kg 1 to 2 h after CHI) as compared to normal cerebrolysin.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Concept

Technology Readiness Level: TRL 3

FIGURES OF MERIT

Value Proposition: I want some financial support to develop this strategy for treatment of heat injury effectively in military personnel for better results and to rehabilitate them most effectively that the available treatment so far.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 38M

Website: www.uu.se

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: None

Primary Sources of Funding: University, Other

Looking for: Both Funding and Development Partners